Novel Targets and Treatments in Oncology and Immunology
Takeda Pharmaceutical are launching an open innovation initiative, inviting researchers to submit their ideas and technologies across five different focus areas, up to £85k / €100k / $150k (AUD). Summarised below are the interests of Takeda relating to novel targets and treatments in oncology and immunology. In the attached application form, each of these subtopics have been expanded upon to give further detail of proposals that would be within scope. In the attached application form, each of these topics have been expanded upon to give further detail of...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile